APMNasdaq
Aptorum Group Ltd
Healthcare·Healthcare·London, United Kingdom
Aptorum Group Ltd (APM): 1 pipeline candidate. Updated within the last hour.
Key Financials
Market Cap
$6.7M
Cash
—
Quarterly Burn
—
Runway
—
Revenue
—
Pipeline (1 candidate)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
6
Total value held
$123K
| Holder | Shares | Value |
|---|---|---|
| citadel advisors llc | 92,420 | $74K |
| susquehanna international group, llp | 16,777 | $13K |
| xtx topco ltd | 15,061 | $12K |
| morgan stanley | 13,262 | $11K |
| renaissance technologies llc | 11,838 | $9K |
| osaic holdings, inc. | 5,500 | $4K |
·CEO: Mr. Chung Yuen Huen
Frequently asked questions
How many drug candidates are in Aptorum Group Ltd's pipeline?
Aptorum Group Ltd (APM) has 1 pipeline candidate tracked by BioSniper across SEC filings and clinical trial registrations.
What is Aptorum Group Ltd's market capitalization?
Aptorum Group Ltd's market capitalization is approximately $6.7M.
Who is the CEO of Aptorum Group Ltd?
Mr. Chung Yuen Huen is the chief executive officer of Aptorum Group Ltd (APM).
Get the full picture on Aptorum Group Ltd
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.